1100
Helvetica Chimica Acta – Vol. 94 (2011)
151.17 (C(2)); 140.38 (C(6)); 110.46 (C(5)); 47.26 (C(7)); 31.29 (C(8)); 29.76 (C(9)); 12.60 (MeꢀC(5)).
Anal. calc. for C8H11BrN2O2 (247.09): C 38.89, H 4.49, N 11.34; found: C 39.32, H 4.73, N 11.47.
1,1’,1’’-(Benzene-1,3,5-triyltrimethanediyl)tris{1’-[3-(3,4-dihydro-5-methyl-2,4-dioxopyrimidin-
1(2H)-yl)propyl]-4,4’-bipyridinium} Hexafluorophosphate (1). A soln. of 1,1’,1’’-(benzene-1,3,5-triyltri-
methanediyl)tris[4-(pyridin-4-yl)pyridinium] trihexafluorophosphate (214 mg, 0.20 mmol) in MeCN
(10 ml) were added to a stirred soln. of 1-(3-bromopropyl)-5-methyl-1H-pyrimidine-2,4-dione (1,570 g,
1.61 mmol) in MeCN (45 ml). The mixture was refluxed for 4 d at 858. The cooled mixture was added
dropwise to 30 ml of a stirred tetrabutylammonium chloride soln. (Bu4NCl; 5% in MeCN). The yellowish
precipitate was filtered off and washed three times with MeCN (10 ml each) and three times with CH2Cl2
(10 ml each). After drying for 24 h in vacuo, the resulting powder was dissolved in H2O (20 ml) and
precipitated with a NH4PF6 soln. (10% in H2O). The residue was washed several times with H2O and
dried in vacuo for 24 h to yield 285 mg of 1 (0.14 mmol, 70%). 1H-NMR (CD3CN): 9.34 (s, HꢀN(3)); 8.98
(d, J ¼ 6.5, HꢀC(5’’,3’’)); 8.93 (d, J ¼ 7.0, HꢀC(5’,3’)); 8.43 – 8.34 (m, HꢀC(2’,6’,2’’,6’’); 7.68 (s,
HꢀC(12,14,16)); 7.24 (s, HꢀC(6)); 5.86 (s, HꢀC(10)); 4.68 (t, J ¼ 7.2, HꢀC(9)); 3.80 (t, J ¼ 6.2,
HꢀC(7)); 2.39 (q, J ¼ 6.7, HꢀC(8)); 1.85 (s, HꢀC(5)). 13C-NMR (CD3CN): 165.4 (C(4)); 152.7 (C(4’’));
151.7 (C(4’’)); 151.1 (C(2)); 146.8 (C(3’,5’,3’’,5’’)); 141.7 (C(6)); 136.1 (C(13,15,11)); 132.8 (C(12,14,16));
128.5 (C(2’,6’,2’’,6’’)); 111,6 (C(5)); 64.8 (C(10)); 60.4 (C(9)); 45.3 (C(7)); 31.4 (C(8)); 12.4 (MeꢀC(5)).
1,1’,1’’-(Benzene-1,3,5-triyltrimethanediyl)tris{1’-[2-(4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)eth-
yl]-4,4’-bipyridinium} Hexachloride (2a). A soln. of 1,1’,1’’-(benzene-1,3,5-triyltrimethanediyl)tris[4-
(pyridin-4-yl)pyridinium] trihexafluorophosphate (81 mg, 0.08 mmol) in MeCN (16 ml) were added in
portions of 1 ml within 4 h to a stirred soln. of 7-(2-bromoethyl)-4-chloro-7H-pyrrolo[2,3-d]pyrimidine
(104 mg, 0.4 mmol) in MeCN (10 ml). The mixture was refluxed for three d at 708. The cooled mixture
was added dropwise to 15 ml of a stirred Bu4NCl soln. (5% in MeCN). The yellowish precipitate was
filtered off and washed three times with MeCN (10 ml each) and three times with CH2Cl2 (10 ml each).
After drying for 24 h in vacuo, 87 mg of 2a (0.067 mmol, 84%) were obtained as a brown powder.
1H-NMR (D2O): 10.0 (d, J ¼ 6.5, HꢀC(6’’,2’’)); 9.45 (d, J ¼ 6.0, HꢀC(6’,2’)); 9.15 (d, J ¼ 6.5, HꢀC(5’’,3’’));
8,95 (d, J ¼ 7.0, HꢀC(5’,3’)); 8.22 (s, HꢀC(12,14,16)); 8.02 (s, HꢀC(2)); 7.85 (d, J ¼ 3.0, HꢀC(6)); 7.10 (d,
J ¼ 4.0, HꢀC(5)); 5.99 (s, HꢀC(10)); 4.89 (t, J ¼ 11.5, HꢀC(8)); 4.06 (t, J ¼ 11.5, HꢀC(9)). 13C-NMR
(D2O): 153.8 (C(4’)); 151.5 (C(4)); 150.9 (C(4’’)); 150.1 (C(6’’,2’’)); 149.3 (C(7a)); 146.0 (C(6’,2’)); 144.6
(C(5’’,3’’)); 135.4 (C(11,13,15)); 134.6 (C(12,14,16)); 130.6 (C(6)); 127.2 (C(5’,3’)); 121.8 (C(2)); 110.1
(C(4a)); 98.0 (C(5)); 62.8 (C(10)); 46.3 (C(8)); 31.5 (C(9)).
1,1’,1’’-(Benzene-1,3,5-triyltrimethanediyl)tris{1’-[2-(2-amino-4-chloro-7H-pyrrolo[2,3-d]pyrimidin-
7-yl)ethyl]-4,4’-bipyridinium} Hexabromide (2b). A soln. of 1,1’,1’’-(benzene-1,3,5-triyltrimethanediyl)-
tris[4-(pyridin-4-yl)pyridinium] trihexafluorophosphate (81 mg, 0.08 mmol) in MeCN (16 ml) were
added dropwise in portions of 1 ml within 4 h to a soln. of 7-(bromomethyl)-4-chloro-7H-pyrrolo[2,3-
d]pyrimidin-2-amine (110 mg, 0.4 mmol) in MeCN (16 ml). The mixture was refluxed for 3 h at 708. The
cooled mixture was filtered, and washed three times with MeCN and Et2O, resp., and dried. The mother
liquor was evaporated, and the residue was dried. The combined solids were resuspended in H2O (15 ml)
and precipitated with 6 ml of a NH4PF6 soln. (10% in H2O). The residue was washed several times with
H2O and dried in vacuo for 48 h. Subsequently, anion-exchange chromatography was applied with 103 mg
of a Brꢀ/PFꢀ6 mixed salt of the crude product and a 5% Bu4NBr soln. (8 ml) to afford 96 mg of 2b
(0.058 mmol, 72%). Pink powder. 1H-NMR (D2O): 9.85 (d, J ¼ 5.0, HꢀC(6’’,2’’)); 9.36 (d, J ¼ 6.0,
HꢀC(6’,2’)); 8.91 (d, J ¼ 6.0, HꢀC(5’’,3’’)); 8.81 (d, J ¼ 5.0, HꢀC(5’,3’)); 7.78 (s, HꢀC(12,14,16)); 7.58 (d,
J ¼ 3.5, HꢀC(10)); 6.78 (d, J ¼ 3.5, HꢀC(11)); 6.15 (s, HꢀC(10)); 4.64 (t, J ¼ 11.0, HꢀC(8)); 3.98 (t, J ¼
11.0, HꢀC(9)). 13C-NMR (D2O): 157.1 (C(2)); 153.1 (C(4’)); 153.9 (C(7a)); 150.6 (C(4’’)); 149.5
(C(4)); 144.9 (C(6’’,2’’)); 144.4 (C(6’,2’)); 136.1 (C(11,13,15,)); 131,3 (C(12,14,16)); 126.9 (C(5’’,3’’));
123.8 (C(5’,3’)); 116.7 (C (4a)); 98.2 (C(6)); 97.8 (C(5)); 62.6 (C(10)); 58.9 (C(8)); 45.1 (C(9)).
REFERENCES
[1] J. E. Betancourt, J. M. Rivera, Org. Lett. 2008, 10, 2287.
[2] F. Puntoriero, P. Ceroni, V. Balzani, G. Bergamini, F. Vçgtle, J. Am. Chem. Soc. 2007, 129, 10714.